Page 32 - Layout 1
P. 32

COVID-19 UPDATE








































        A Disease of Insufficient Nitric Oxide Production


        By Nathan S. Bryan, PhD


                                                                                          3
          COVID-19 is now a worldwide pandemic affecting millions of   untreated cardiovascular conditions.  It is clear that older people with
        people around the world. As of mid-May 2021, over 160 million peo-  an underlying comorbidity such as high blood pressure, heart disease,
        ple have been infected, with over three million deaths. Early data com-  kidney disease, obesity, smokers and patients with pulmonary disor-
        ing out of China in January 2020 revealed that patients with   ders are at an increased risk of COVID infection. These are also the
        underlying cardiovascular disease were more susceptible to infection,   people that get the sickest and die from COVID.
        greater disease severity and ten times higher mortality. Among the pa-  Additionally, abnormal blood clotting is an increasingly recognized
        tients studied, the median (range) age was 64 (21-95) years old, female   complication of this disease, both systemically and within the pul-
                                                                              4
        (50.7%, and the median time to symptom onset was 10 days (in-  monary circulation.  In fact, one of the greatest predictors of death is a
        terquartile range [IQR]), 1-30). Of this group, 82 (19.7%) had some   serum blood test that indicates elevated clotting activity (D-dimer).
        type of cardiac comorbidity. It was apparent as the study went on that   More recent clinical observations reveal endothelial cell infection and
        patients with cardiac morbidity and COVID-19 fared worse than the   endotheliitis in COVID patients across vascular beds in multiple
                                                                    5
        patients with COVID-19, but no history of cardiac morbidity. Pa-  organs.  The vascular endothelium is an active paracrine, endocrine and
        tients with cardiac morbidity with diagnosed COVID-19, compared   autocrine organ that is indispensable for the regulation of vascular tone
        with patients without cardiac morbidity, had a higher mortality rate   and the maintenance of vascular homoeostasis.  COVID-19-endothe-
                                                                                                 6
                                  1
        (51.2% vs 4.5%) and risk of death.                     liitis could explain the systemic impaired microcirculatory function in
          In addition, over the past 18 months, reports from the U.S. database   different vascular beds and their clinical sequelae in patients with
        compiled by CDC report mortality from COVID-19 to have a racial   COVID-19.  Endothelial dysfunction and insufficient nitric oxide
               2
        disparity.  A disproportionate number of COVID-19 fatalities among   (NO) production is a principal determinant of microvascular dysfunc-
        Hispanics and African Americans has been observed. This has been   tion by shifting the vascular equilibrium towards more vasoconstriction
        attributed to known disparities in health care, low economic resources   with subsequent organ ischemia, inflammation with associated tissue
        and issues associated with social distancing: occupation, crowded res-  edema and a pro-coagulant state. See illustration. Therefore, the people
        idential spaces and transportation crowding. Additionally, Hispanics   that are most susceptible and vulnerable to COVID infection are exactly
        and African Americans have a high incidence of pre-existing and often   the patients that have insufficient nitric oxide production in their body.


         32     SAN ANTONIO MEDICINE  • July 2021
   27   28   29   30   31   32   33   34   35   36   37